Sign up to save your podcasts
Or
Share Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)
Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s Becky Knockemus talks with Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA).
View all episodes
By Chris O'Brien
5
1212 ratings
Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s Becky Knockemus talks with Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA).
More shows like Few & Far Between: Conversations from the Front Lines of Drug Development
View all
This American Life
90,400 Listeners
The Daily
111,059 Listeners
The Readout Loud
316 Listeners
BioCentury This Week
30 Listeners
Biotech Hangout
17 Listeners
The BioCentury Show
11 Listeners